BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

484 related articles for article (PubMed ID: 19254517)

  • 1. Selective serotonin reuptake inhibitor exposure during early pregnancy and the risk of fetal major malformations: focus on paroxetine.
    Gentile S; Bellantuono C
    J Clin Psychiatry; 2009 Mar; 70(3):414-22. PubMed ID: 19254517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of depressed pregnant women by selective serotonin reuptake inhibitors: risk for the foetus and the newborn].
    Favrelière S; Nourrisson A; Jaafari N; Pérault Pochat MC
    Encephale; 2010 Jun; 36 Suppl 2():D133-8. PubMed ID: 20513456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paroxetine and congenital malformations: meta-Analysis and consideration of potential confounding factors.
    Bar-Oz B; Einarson T; Einarson A; Boskovic R; O'Brien L; Malm H; Bérard A; Koren G
    Clin Ther; 2007 May; 29(5):918-926. PubMed ID: 17697910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First trimester exposure to paroxetine and risk of cardiac malformations in infants: the importance of dosage.
    Bérard A; Ramos E; Rey E; Blais L; St-André M; Oraichi D
    Birth Defects Res B Dev Reprod Toxicol; 2007 Feb; 80(1):18-27. PubMed ID: 17187388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Publishing statistically significant results with questionable clinical importance: focus on antidepressant use in pregnancy.
    Einarson A
    J Clin Psychiatry; 2012 Nov; 73(11):1443-6. PubMed ID: 23218161
    [No Abstract]   [Full Text] [Related]  

  • 6. SSRI antidepressants and birth defects.
    Prescrire Int; 2006 Dec; 15(86):222-3. PubMed ID: 17167929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paroxetine and fluoxetine in pregnancy: a prospective, multicentre, controlled, observational study.
    Diav-Citrin O; Shechtman S; Weinbaum D; Wajnberg R; Avgil M; Di Gianantonio E; Clementi M; Weber-Schoendorfer C; Schaefer C; Ornoy A
    Br J Clin Pharmacol; 2008 Nov; 66(5):695-705. PubMed ID: 18754846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pregnancy outcome after exposure to antidepressants and the role of maternal depression: results from the Norwegian Mother and Child Cohort Study.
    Nordeng H; van Gelder MM; Spigset O; Koren G; Einarson A; Eberhard-Gran M
    J Clin Psychopharmacol; 2012 Apr; 32(2):186-94. PubMed ID: 22367660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonin reuptake inhibitor antidepressants and pregnancy: many unanswered questions.
    Prescrire Int; 1999 Oct; 8(43):157-9. PubMed ID: 11503843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antidepressant use in pregnancy: a critical review focused on risks and controversies.
    Byatt N; Deligiannidis KM; Freeman MP
    Acta Psychiatr Scand; 2013 Feb; 127(2):94-114. PubMed ID: 23240634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical management of perinatal depression: focus on paroxetine.
    Newport DJ; Stowe ZN
    Psychopharmacol Bull; 2003; 37 Suppl 1():148-66. PubMed ID: 14566197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective serotonin reuptake inhibitor exposure during early pregnancy and the risk of birth defects.
    Gentile S
    Acta Psychiatr Scand; 2011 Apr; 123(4):266-75. PubMed ID: 21261600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of selective serotonin reuptake inhibitors during pregnancy and risk of major and cardiovascular malformations: an update.
    Tuccori M; Montagnani S; Testi A; Ruggiero E; Mantarro S; Scollo C; Pergola A; Fornai M; Antonioli L; Colucci R; Corona T; Blandizzi C
    Postgrad Med; 2010 Jul; 122(4):49-65. PubMed ID: 20675971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurodevelopment of children following prenatal exposure to venlafaxine, selective serotonin reuptake inhibitors, or untreated maternal depression.
    Nulman I; Koren G; Rovet J; Barrera M; Pulver A; Streiner D; Feldman B
    Am J Psychiatry; 2012 Nov; 169(11):1165-74. PubMed ID: 23128923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The risk of major cardiac malformations associated with paroxetine use during the first trimester of pregnancy: a systematic review and meta-analysis.
    Bérard A; Iessa N; Chaabane S; Muanda FT; Boukhris T; Zhao JP
    Br J Clin Pharmacol; 2016 Apr; 81(4):589-604. PubMed ID: 26613360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [SSRIs and pregnancy: a review of the literature].
    Soufia M; Aoun J; Gorsane MA; Krebs MO
    Encephale; 2010 Dec; 36(6):513-6. PubMed ID: 21130237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neonatal symptoms following maternal paroxetine treatment: serotonin toxicity or paroxetine discontinuation syndrome?
    Haddad PM; Pal BR; Clarke P; Wieck A; Sridhiran S
    J Psychopharmacol; 2005 Sep; 19(5):554-7. PubMed ID: 16166193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prenatal exposure to selective serotonin reuptake inhibitors and infant outcome.
    Malm H
    Ther Drug Monit; 2012 Dec; 34(6):607-14. PubMed ID: 23042258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An imperfect literature and evidence-based medicine.
    Freeman MP
    J Clin Psychiatry; 2009 Mar; 70(3):412-3. PubMed ID: 19317958
    [No Abstract]   [Full Text] [Related]  

  • 20. Early pregnancy exposure to selective serotonin reuptake inhibitors, risks of major structural malformations, and hypothesized teratogenic mechanisms.
    Gentile S
    Expert Opin Drug Metab Toxicol; 2015; 11(10):1585-97. PubMed ID: 26135630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.